These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 15063782

  • 1. Cyclin-dependent kinase 2 regulates the interaction of Axin with beta-catenin.
    Kim SI, Park CS, Lee MS, Kwon MS, Jho EH, Song WK.
    Biochem Biophys Res Commun; 2004 Apr 30; 317(2):478-83. PubMed ID: 15063782
    [Abstract] [Full Text] [Related]

  • 2. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S, Kishida M, Matsuura Y, Usui H, Kikuchi A.
    Oncogene; 2000 Jan 27; 19(4):537-45. PubMed ID: 10698523
    [Abstract] [Full Text] [Related]

  • 3. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A.
    EMBO J; 1998 Mar 02; 17(5):1371-84. PubMed ID: 9482734
    [Abstract] [Full Text] [Related]

  • 4. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
    Jho Eh, Lomvardas S, Costantini F.
    Biochem Biophys Res Commun; 1999 Dec 09; 266(1):28-35. PubMed ID: 10581160
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
    Ha NC, Tonozuka T, Stamos JL, Choi HJ, Weis WI.
    Mol Cell; 2004 Aug 27; 15(4):511-21. PubMed ID: 15327768
    [Abstract] [Full Text] [Related]

  • 6. Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin.
    Cong F, Varmus H.
    Proc Natl Acad Sci U S A; 2004 Mar 02; 101(9):2882-7. PubMed ID: 14981260
    [Abstract] [Full Text] [Related]

  • 7. Axin prevents Wnt-3a-induced accumulation of beta-catenin.
    Kishida M, Koyama S, Kishida S, Matsubara K, Nakashima S, Higano K, Takada R, Takada S, Kikuchi A.
    Oncogene; 1999 Jan 28; 18(4):979-85. PubMed ID: 10023673
    [Abstract] [Full Text] [Related]

  • 8. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.
    Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, Pettman G, Mannix C, Culbert AA, Brown MJ, Smith DG, Reith AD.
    Structure; 2001 Dec 28; 9(12):1143-52. PubMed ID: 11738041
    [Abstract] [Full Text] [Related]

  • 9. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.
    Willert K, Shibamoto S, Nusse R.
    Genes Dev; 1999 Jul 15; 13(14):1768-73. PubMed ID: 10421629
    [Abstract] [Full Text] [Related]

  • 10. Synaptic scaffolding molecule interacts with axin.
    Hirabayashi S, Nishimura W, Iida J, Kansaku A, Kishida S, Kikuchi A, Tanaka N, Hata Y.
    J Neurochem; 2004 Jul 15; 90(2):332-9. PubMed ID: 15228590
    [Abstract] [Full Text] [Related]

  • 11. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
    Fagotto F, Jho Eh, Zeng L, Kurth T, Joos T, Kaufmann C, Costantini F.
    J Cell Biol; 1999 May 17; 145(4):741-56. PubMed ID: 10330403
    [Abstract] [Full Text] [Related]

  • 12. Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin.
    Hinoi T, Yamamoto H, Kishida M, Takada S, Kishida S, Kikuchi A.
    J Biol Chem; 2000 Nov 03; 275(44):34399-406. PubMed ID: 10906131
    [Abstract] [Full Text] [Related]

  • 13. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C, Weiss JB, Williams LT.
    Proc Natl Acad Sci U S A; 1998 Mar 17; 95(6):3020-3. PubMed ID: 9501208
    [Abstract] [Full Text] [Related]

  • 14. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin.
    Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S, Kikuchi A.
    J Biol Chem; 1998 May 01; 273(18):10823-6. PubMed ID: 9556553
    [Abstract] [Full Text] [Related]

  • 15. Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex.
    Xing Y, Clements WK, Kimelman D, Xu W.
    Genes Dev; 2003 Nov 15; 17(22):2753-64. PubMed ID: 14600025
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding.
    Webster MT, Rozycka M, Sara E, Davis E, Smalley M, Young N, Dale TC, Wooster R.
    Genes Chromosomes Cancer; 2000 Aug 15; 28(4):443-53. PubMed ID: 10862053
    [Abstract] [Full Text] [Related]

  • 20. Axin directly interacts with plakoglobin and regulates its stability.
    Kodama S, Ikeda S, Asahara T, Kishida M, Kikuchi A.
    J Biol Chem; 1999 Sep 24; 274(39):27682-8. PubMed ID: 10488109
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.